Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IOngoingD-0084-2025

Drug recall · December 11, 2024

PeakMax Capsules recall

Why: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com

Lots / codes

Lot #: 230811, Exp: 08/11/2025

Quantity
Unknown
Company
Boulla LLC, Sacramento, CA
Distribution
Nationwide within the United States
Initiated
November 4, 2024 · Voluntary: Firm initiated
Classified
December 2, 2024
Reported
December 11, 2024
How notified
E-Mail

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.